DDX5 and breast carcinoma: DDX5 has been found to regulate the biogenesis of a subset of miRNAs, targeting different downstream mRNAs (e.g., PDCD4 via miR-21, cofilin and profilin via miR-182) and thus promoting the progression of breast cancer.